Sedative effects of alpha-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002645:Chickens; D002697:Chloral Hydrate / Q000037:antagonists & inhibitors; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D005260:Female; D006993:Hypnotics and Sedatives / Q000037:antagonists & inhibitors; D008464:Mecamylamine / Q000494:pharmacology; D051379:Mice; D009278:Naphazoline / Q000037:antagonists & inhibitors; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000037:antagonists & inhibitors*; D014043:Tolazoline / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D006993:Hypnotics and Sedatives; D013565:Sympatholytics; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D002697:Chloral Hydrate; D003983:Dibenzylchlorethamine; D008464:Mecamylamine; D001285:Atropine; D014043:Tolazoline; D009278:Naphazoline; D010646:Phentolamine